Stockscreener 앱 받기
0.7212
0.51%
-0.0037
시간 외 거래:
.73
0.0088
+1.22%
전일 마감가:
$0.7249
열려 있는:
$0.711
하루 거래량:
199.08K
Relative Volume:
0.39
시가총액:
$27.77M
수익:
$40.93M
순이익/손실:
$-15.57M
주가수익비율:
-1.9371
EPS:
-0.3723
순현금흐름:
$-17.84M
1주 성능:
+4.81%
1개월 성능:
-5.06%
6개월 성능:
-17.10%
1년 성능:
-86.84%
1일 변동 폭
$0.6869
$0.733
1주일 범위
$0.626
$0.779
52주 변동 폭
$0.626
$5.6199
Myomo Inc Stock (MYO) Company Profile
명칭
Myomo Inc
전화
617-996-9058
주소
One Broadway, 14th Floor, Cambridge, MA
Compare MYO vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
0.7212 | 27.92M | 40.93M | -15.57M | -17.84M | -0.3723 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-31 | 개시 | Craig Hallum | Buy |
| 2024-05-20 | 개시 | Lake Street | Buy |
| 2023-12-15 | 개시 | H.C. Wainwright | Buy |
| 2020-11-11 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2020-05-27 | 개시 | Dougherty & Company | Buy |
| 2017-10-02 | 개시 | H.C. Wainwright | Buy |
모두보기
Myomo Inc 주식(MYO)의 최신 뉴스
Getz Heather C, director at Myomo, buys $13,972 in stock - Investing.com
Myomo (MYO) director Heather Getz purchases 20,000 common shares - Stock Titan
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates - MSN
2026 Week #11: Where “Exoskeleton” Came From, Myomo Expands Coverage, Exo Games Return - Exoskeleton Report
Kirk Thomas F buys Myomo (MYO) shares worth $51,112 - Investing.com
Kirk Thomas F buys Myomo (MYO) shares worth $51,112 By Investing.com - Investing.com India
Myomo (MYO) director adds 72,000 MYO shares in open-market purchase - Stock Titan
Elevance Expands Myomo Coverage And Broadens Technology Enabled Care Story - Sahm
MYOMO (MYO) director boosts stake with 70,000-share open-market buy - Stock Titan
Elevance Expands Myomo Coverage To Support Tech Enabled Care Narrative - Yahoo Finance
Myomo price target lowered to $3 from $4 at Alliance Global - TipRanks
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH), Myomo (MYO) and OS Therapies Incorporated (OSTX) - The Globe and Mail
Myomo Inc. Flags High Risk in Forward-Looking Statements, Urges Caution on Reimbursement, Financing and Growth Plans - The Globe and Mail
Myomo Inc (MYO) Q4 2025 Earnings Call Highlights: Record Revenue - GuruFocus
Craig-Hallum Maintains Buy on Myomo, Inc. (MYO) March 2026 - Meyka
Craig-Hallum cuts Myomo stock price target to $1.10 on guidance miss - Investing.com Australia
Myomo enters network agreement with Elevance Health plans - Investing.com Australia
Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH), Myomo (MYO) and Hims & Hers Health (HIMS) - The Globe and Mail
Myomo, Inc. 2026 Annual Report: Market Leadership, Competitive Risks, and Myoelectric Orthotics Business Overview - Minichart
Myomo’s operating loss hits USD 2.8M in Q4 2025 - Medical Buyer
MYO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
Myomo Q4 2025 Earnings Call Transcript - MarketBeat
Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates - Bitget
Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - 01net
Myomo earnings missed, revenue topped estimates By Investing.com - Investing.com Canada
Myomo reports Q4 EPS (9c), consensus (9c) - TipRanks
MYO Posts Strong Q4 Revenue Surpassing Expectations - GuruFocus
Myomo (MYO) Projects Lower Q1 Revenue Amid Market Expectations - GuruFocus
Myomo sees FY26 revenue $43M-$46M, consensus $46.97M - TipRanks
Myomo, Elevance agree to contract for multi-state network participation - TipRanks
Elevance Health (ELV) Partners with Myomo to Expand Access to My - GuruFocus
Myomo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Myomo Q4 revenue falls on lower average selling price - TradingView
Myomo (NYSE: MYO) grows 2025 revenue 26% but posts larger annual loss - Stock Titan
Earnings Breakdown: Myomo Q4 - Benzinga
BRIEF-Myomo Q4 EPS USD -0.09 - TradingView
Myomo and Elevance Health Agree to Contract for Multi-State Network Participation - Business Wire
Gains Recap: Can Myomo Inc sustain earnings growth2025 Growth vs Value & Fast Entry Momentum Alerts - baoquankhu1.vn
Myomo to Announce Q4 Earnings on March 9 - Intellectia AI
Myomo (MYO) Set to Release Q4 Earnings with High Expectations - GuruFocus
Market Fear: Is Myomo Inc a potential multi bagger2025 Risk Factors & Fast Gain Swing Alerts - baoquankhu1.vn
Preview: Myomo's Earnings - Benzinga
Aug Sectors: Will Myomo Inc benefit from geopolitical trendsJuly 2025 Market Mood & Risk Managed Investment Signals - baoquankhu1.vn
Myomo to Report Fourth Quarter 2025 Financial Results on March 9 - 01net
Myomo (MYO) Projected to Post Quarterly Earnings on Monday - Defense World
MYO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
MYO PE Ratio & Valuation, Is MYO Overvalued - Intellectia AI
Will Myomo Inc. benefit from geopolitical trendsJuly 2025 Retail & Low Drawdown Momentum Ideas - mfd.ru
Rosalind Advisors, Inc. Expands Stake in Myomo Inc. - GuruFocus
Market Catalysts: Can INTZ be recession proofEarnings Recap Report & Weekly Watchlist of Top Performers - baoquankhu1.vn
Myomo Inc (MYO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):